Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

159.02
-2.4800-1.54%
Post-market: 158.88-0.1400-0.09%17:23 EDT
Volume:1.86M
Turnover:293.88M
Market Cap:21.34B
PE:-45.39
High:162.14
Open:160.01
Low:155.63
Close:161.50
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.06
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-95.75
PE(LYR):-47.89

Loading ...

Phase 2b JAMA Data and New Financing Tools Could Be A Game Changer For GH Research (GHRS)

Simply Wall St.
·
May 18

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)

TIPRANKS
·
May 16

These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga Earnings
·
May 15

GH Research price target raised to $35 from $25 at Cantor Fitzgerald

TIPRANKS
·
May 15

GH Research Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
May 15

GH Research Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 15

Canaccord Genuity Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
May 15

GH Research price target lowered to $39 from $42 at Citizens

TIPRANKS
·
May 15

GH Research Launches $200 Million At-the-Market Share Offering With Stifel

TIPRANKS
·
May 15

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

TIPRANKS
·
May 15

GH Research Reports Widened Net Loss Per Share to $0.31 in Q1 Amid Increased R&D Investment

Deep News
·
May 14

GH Research files $400M mixed securities shelf

TIPRANKS
·
May 14

GH Research reports Q1 EPS (31c), consensus (26c)

TIPRANKS
·
May 14

GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise

TIPRANKS
·
May 14

Earnings Flash (GHRS) GH Research Posts Q1 Loss $0.31 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
May 14

GH Research Q1 EPS $(0.31) Misses $(0.28) Estimate

Benzinga Earnings
·
May 14

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Guardant Health (GH) Receives a Buy from Morgan Stanley

TIPRANKS
·
May 12

Guardant Health price target raised to $135 from $130 at Piper Sandler

TIPRANKS
·
May 12

Guardant Health (GH) Gets a Buy from Wells Fargo

TIPRANKS
·
May 12